Hypertension, diabetes, and headache

Levy, Richard L.; Singer, Karl
May 1997
Patient Care;5/15/1997, Vol. 31 Issue 9, p210
Academic Journal
Presents the case of a 46-year old hypertensive diabetic man experiencing left temporal headaches. History of present illness; Differential diagnosis; Clinical management.


Related Articles

  • Differential effects of enalapril and atenolol on proteinuria and renal haemodynamics in non-diabetic renal disease. Apperloo, Alfred J.; De Zeeuw, Dick; Sluiter, Henk E.; De Jong, Paul E. // BMJ: British Medical Journal (International Edition);10/5/91, Vol. 303 Issue 6806, p821 

    Focuses on the effects of enalapril and atenolol on proteinuria and renal hemodynamics in non-diabetic disease. Pretreatment on the diastolic blood pressure; Significance of the falls of the systolic and diastolic blood pressures; Characterization of the renal hemodynamics effect of the...

  • Control of hypertension in diabetes. Tuck, Michael L. // Diabetes Care;Feb2003, Vol. 26 Issue 2, p534 

    Focuses on the control of hypertension in diabetes. Antihypertensive therapy; Threshold for hypertension control; Glycemic control in diabetes.

  • Managing hypertension in patients with diabetes.  // Patient Care;1/30/1994, Vol. 28 Issue 2, p15 

    Discusses the treatment of hypertension in diabetic patients. Urgency in the determination of the appropriate treatment of the hypertensive diabetic; Necessary lifestyle changes; Angiotensin converting enzyme inhibitors as drugs of choice.

  • Meta-analysis of Hypertension Trials in Diabetic Patients. Pahor, Marco; Psaty, Bruce M.; Alderman, Michael H.; Furberg, Curt D. // Diabetes Care;Jan2001, Vol. 24 Issue 1, p178 

    Comments on the United Kingdom Prospective Diabetes Study wherein hypertension trials in diabetic patients were analyzed. Limitations of the study; Implications; Results of comparative trials in hypertension.

  • The Factual Implications of Diabetes. Coopman, Robert // Chain Drug Review;3/18/2013, Vol. 35 Issue 5, p86 

    The article discusses some conditions associated with diabetes and diabetes complications, including diabetic retinopathy, hypertension or heart disease, and kidney function decline.

  • Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they... Samuelsson, Ola; Pennert, Kjell // BMJ: British Medical Journal (International Edition);9/14/96, Vol. 313 Issue 7058, p660 

    Presents a study on the correlation between long term treatment with antihypertensive drugs and increased risk of coronary heart disease. Risk factors to coronary heart disease; Impact of metabolic diseases on the prognosis for treated hypertensive patients.

  • Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Janssen, Ulf; Riley, Stephen G.; Vassiliadou, Athina; Floege, Jürgen; Phillips, Aled O. // Kidney International;Jun2003, Vol. 63 Issue 6, p2162 

    Hypertension superimposed on type II diabetes in Goto Kakizaki rats induces progressive nephropathy. Background. Type II diabetes in the Goto Kakizaki (GK) rats (derived from Wistar rats) is not associated with the development of obesity, hyperlipidemia, hypertension, or pronounced renal...

  • Overcoming Barriers to Evidence-Based Diabetes Care. Grant, Richard W.; Meigs, James B. // Current Diabetes Reviews;2006, Vol. 2 Issue 2, p261 

    Despite evidence-based guidelines that advocate aggressive management of hyperglycemia, hypertension, and hyperlipidemia, patients with diabetes continue to suffer from high rates of cardiovascular and microvascular complications and can expect a lifespan reduction of 10 to 15 years. Our current...

  • Spironolactone treatment in patients with diabetic microalbuminuria and resistant hypertension. Kota, Sunil; Jammula, Sruti; Kota, Siva; Meher, Lalit; Modi, Kirtikumar // International Journal of Diabetes in Developing Countries;Jan-Mar2012, Vol. 32 Issue 1, p33 

    Resistant hypertension is common in diabetes. Spironolactone by inhibiting aldosterone not only exerts antihypertensive effect but also antiproteinuric effect. In this study, the mean decrease in systolic and diastolic blood pressure after 4 weeks of spironolactone was 25.5 ± 7.8 and 11.4...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics